Decreased risk of liver cancer with thiazolidinediones therapy in patients with type 2 diabetes: Results from a meta-analysis

Authors


  • Potential conflict of interest: Nothing to report.

    Supported by grants Shanghai Natural Science Foundation of China (Grant No. 12ZR1447500), and State Key Program of National Natural Science of China (Grant No. 81230057).

No abstract is available for this article.

Ancillary